A detailed history of Eco R1 Capital, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 19,209,643 shares of NUVB stock, worth $58.4 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
19,209,643
Previous 19,209,643 -0.0%
Holding current value
$58.4 Million
Previous $29 Million 141.06%
% of portfolio
1.99%
Previous 0.84%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$1.26 - $2.1 $6.69 Million - $11.2 Million
5,313,100 Added 38.23%
19,209,643 $25.7 Million
Q4 2021

Feb 14, 2022

BUY
$7.75 - $10.05 $1.43 Million - $1.86 Million
185,026 Added 1.35%
13,896,543 $118 Million
Q2 2021

Aug 16, 2021

BUY
$9.22 - $14.48 $4.28 Million - $6.73 Million
464,500 Added 3.51%
13,711,517 $128 Million
Q1 2021

May 17, 2021

BUY
$9.0 - $14.57 $119 Million - $193 Million
13,247,017 New
13,247,017 $138 Million

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $660M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.